Updated Jul 16, 2026
Berkowitz Noah has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $249K.

Noah Berkowitz is a medical professional and the Chief Medical Officer at Arvinas, Inc., a biotechnology company focused on developing therapies for cancer and other diseases through targeted protein degradation. He has extensive experience in clinical development and medical affairs in the pharmaceutical industry.
| Role | Chief Medical Officer |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | ARVN | ARVINAS, INC. | S — Open-market sale | 11.1K | $9.94 | $110K |
| 2026-03-20 | ARVN | ARVINAS, INC. | S — Open-market sale | 6.4K | $11.10 | $71K |
| 2026-03-03 | ARVN | ARVINAS, INC. | A — Grant or award | 45.0K | $0.00 | |
| 2026-02-18 | ARVN | ARVINAS, INC. | S — Open-market sale | 5.7K | $11.89 | $68K |
Noah Berkowitz is a medical professional and the Chief Medical Officer at Arvinas, Inc., a biotechnology company focused on developing therapies for cancer and other diseases through targeted protein degradation. He has extensive experience in clinical development and medical affairs in the pharmaceutical industry.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($249K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Berkowitz Noah profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.